These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

440 related items for PubMed ID: 22525978

  • 1. Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study.
    Garnero P, Sornay-Rendu E, Munoz F, Borel O, Chapurlat RD.
    Osteoporos Int; 2013 Feb; 24(2):489-94. PubMed ID: 22525978
    [Abstract] [Full Text] [Related]

  • 2. Serum parathyroid hormone is associated with increased cortical porosity of the inner transitional zone at the proximal femur in postmenopausal women: the Tromsø Study.
    Osima M, Borgen TT, Lukic M, Grimnes G, Joakimsen RM, Eriksen EF, Bjørnerem Å.
    Osteoporos Int; 2018 Feb; 29(2):421-431. PubMed ID: 29134242
    [Abstract] [Full Text] [Related]

  • 3. Serum sclerostin levels associated with lumbar spine bone mineral density and bone turnover markers in patients with postmenopausal osteoporosis.
    Xu XJ, Shen L, Yang YP, Lu FR, Zhu R, Shuai B, Li CG, Wu MX.
    Chin Med J (Engl); 2013 Jul; 126(13):2480-4. PubMed ID: 23823821
    [Abstract] [Full Text] [Related]

  • 4. Associations of vitamin D status with bone mineral density, bone turnover, bone loss and fracture risk in healthy postmenopausal women. The OFELY study.
    Garnero P, Munoz F, Sornay-Rendu E, Delmas PD.
    Bone; 2007 Mar; 40(3):716-22. PubMed ID: 17112798
    [Abstract] [Full Text] [Related]

  • 5. Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women--the six-month effect of risedronate and teriparatide.
    Polyzos SA, Anastasilakis AD, Bratengeier C, Woloszczuk W, Papatheodorou A, Terpos E.
    Osteoporos Int; 2012 Mar; 23(3):1171-6. PubMed ID: 21305266
    [Abstract] [Full Text] [Related]

  • 6. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
    Gao C, Qiao J, Li SS, Yu WJ, He JW, Fu WZ, Zhang ZL.
    Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
    [Abstract] [Full Text] [Related]

  • 7. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study.
    Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD.
    J Bone Miner Res; 2000 Aug; 15(8):1526-36. PubMed ID: 10934651
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Biochemical markers of bone turnover and risk of incident hip fracture in older women: the Cardiovascular Health Study.
    Massera D, Xu S, Walker MD, Valderrábano RJ, Mukamal KJ, Ix JH, Siscovick DS, Tracy RP, Robbins JA, Biggs ML, Xue X, Kizer JR.
    Osteoporos Int; 2019 Sep; 30(9):1755-1765. PubMed ID: 31227885
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women: the Center of Excellence for Osteoporosis Research Study.
    Ardawi MS, Rouzi AA, Al-Sibiani SA, Al-Senani NS, Qari MH, Mousa SA.
    J Bone Miner Res; 2012 Dec; 27(12):2592-602. PubMed ID: 22836717
    [Abstract] [Full Text] [Related]

  • 12. Associations of serum sclerostin and polymorphisms in the SOST gene with bone mineral density and markers of bone metabolism in postmenopausal Chinese women.
    He J, Zhang H, Wang C, Zhang Z, Yue H, Hu W, Gu J, Fu W, Hu Y, Li M, Liu Y, Zheng H, Zhang Z.
    J Clin Endocrinol Metab; 2014 Apr; 99(4):E665-73. PubMed ID: 24423318
    [Abstract] [Full Text] [Related]

  • 13. Oxytocin and bone status in men: analysis of the MINOS cohort.
    Breuil V, Fontas E, Chapurlat R, Panaia-Ferrari P, Yahia HB, Faure S, Euller-Ziegler L, Amri EZ, Szulc P.
    Osteoporos Int; 2015 Dec; 26(12):2877-82. PubMed ID: 26109496
    [Abstract] [Full Text] [Related]

  • 14. Role of sclerostin in the bone loss of postmenopausal chinese women with type 2 diabetes.
    Zhou YJ, Li A, Song YL, Zhou H, Li Y, Tang YS.
    Chin Med Sci J; 2013 Sep; 28(3):135-9. PubMed ID: 24074614
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Calciotropic Hormones and the Prevalence of Vertebral Fractures in Chinese Postmenopausal Women with Vitamin D Insufficiency: Peking Vertebral Fracture Study.
    Jiajue R, Jiang Y, Qi X, Wang Q, Wang W, Pei Y, Wang X, Huang W, Zheng X, Ning Z, Wang O, Li M, Xing X, Yu W, Xu L, Xia W.
    Calcif Tissue Int; 2019 Jun; 104(6):622-630. PubMed ID: 30737534
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Relationship Between Serum 25-Hydroxyvitamin D and Bone Mineral Density, Fracture Risk, and Bone Metabolism in Adults With Osteoporosis/Fractures.
    Chen FP, Lin YC, Lin YJ, Huang MH, Chen JF, Lai PL, Chang CW, Yin TC.
    Endocr Pract; 2024 Jul; 30(7):616-623. PubMed ID: 38692490
    [Abstract] [Full Text] [Related]

  • 19. Circulating sclerostin and estradiol levels are associated with inadequate response to bisphosphonates in postmenopausal women with osteoporosis.
    Morales-Santana S, Díez-Pérez A, Olmos JM, Nogués X, Sosa M, Díaz-Curiel M, Pérez-Castrillón JL, Pérez-Cano R, Torrijos A, Jodar E, Rio LD, Caeiro-Rey JR, Reyes-García R, García-Fontana B, González-Macías J, Muñoz-Torres M.
    Maturitas; 2015 Dec; 82(4):402-10. PubMed ID: 26358930
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.